Regulatory Story
Go to market news section View chart   Print
Tate & Lyle PLC  -  TATE   

Director/PDMR Shareholding - Replacement

Released 09:08 19-Jun-2013

Director/PDMR Shareholding - Replacement

LONDON--(BUSINESS WIRE)--

Tate & Lyle PLC

The following amendment has been made to the ‘Directors/PDMR Shareholding’ announcement released on 8 January 2013 at 17:00.

The number of shares acquired by Robert Walker should read 108 instead of 148 and the total number of shares held by him following the purchase should be 11,786 instead of 11,826.

All other details remain unchanged.

The full amended text is shown below.

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) announces that following the purchase of ordinary 25p shares (“Shares”) on 4 January 2013 under the terms of the Tate & Lyle PLC Dividend Reinvestment Plan (“DRIP”), the Company was informed that the following directors of the Company have acquired interests in additional Shares at a purchase price of 791.75 pence per share:

Name   No. of Shares acquired   Date of notification to the Company   Total No. of Shares held following purchase
Sir Peter Gershon (Chairman)   639   08/01/2013   70,138
Javed Ahmed (Chief Executive)   9,636   07/01/2013   1,050,915
Tim Lodge (Chief Financial Officer)   491   07/01/2013   53,561
Robert Walker   108   08/01/2013   11,786
     

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FSA’s Disclosure and Transparency Rules.

Lucie Gilbert
Company Secretary

19 June 2013

Tate & Lyle PLC

Source: Tate & Lyle PLC


Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Director/PDMR Shareholding - Replacement - RNS